Back to today’s briefing

Story perspectives

Tahoe Therapeutics Launches 100M Dataset to Transform Cancer Treatment

8/11/2025

50 10

Summary

Story summary

Tahoe Therapeutics has unveiled Tahoe-100M, an impressive dataset featuring 100 million datapoints that track cancer cell responses to over 1,000 molecules, revolutionizing AI-driven drug discovery. With a recent $30 million funding boost, totaling $42 million, Tahoe is on a mission to develop virtual cell models to expedite cancer treatment and is actively pursuing FDA studies for a promising drug candidate.

1 of 1

Story summary

Tahoe Therapeutics has unveiled Tahoe-100M, an impressive dataset featuring 100 million datapoints that track cancer cell responses to over 1,000 molecules, revolutionizing AI-driven drug discovery. With a recent $30 million funding boost, totaling $42 million, Tahoe is on a mission to develop virtual cell models to expedite cancer treatment and is actively pursuing FDA studies for a promising drug candidate.